title: Identification of a mesothelioma phenotype.
abstract: Despite the strong association of asbestos exposure to mesothelioma, only a fraction of persons exposed develop this neoplasm which is characterized by long latency and shortened survival. Familial clustering implicates both exposure and genetic predisposition as causative, but a biologically relevant mesothelioma phenotype essential to genetic analysis has not been defined. To identify a more extensive set of traits that would define a mesothelioma phenotype for the purpose of genetic analysis, we set to determine characteristics that distinguish mesothelioma patients from others exposed to asbestos and to identify factors that predict the presence of mesothelioma over other mesenchymal tumors of the peritoneum and carcinoma metastatic to the pleura. We compared demographics in four asbestos-exposed groups (controls n=347, bronchogenic cancer n=67, mesothelioma n=179 and benign asbestos-induced lung disease (BALD) n=3757). Within the mesothelioma group, we compared traits to identify characteristics associated with shortened survival. We found that compared to other asbestos-exposed groups, subjects with mesothelioma were younger at first asbestos exposure, had a greater risk of a second cancer diagnosis (odds ratio=3.29), had a longer disease latency, and had a greater risk of cancer among first-degree relatives (point estimate for risk 2.93; 95% CI 2.5-3.5). Thoracic tumor location, work exposure and male gender were consistently associated with shortened survival (1.9+/-1.3 years). We conclude that thoracic tumor location, work exposure, male gender, long latency, early age at first exposure, presence of a second cancer, and first-degree relative with cancer define a phenotype that sets mesothelioma patients with a short survival apart from other asbestos-exposed individuals. We propose that this phenotype be applied to candidate gene analysis.
authors.affiliation: Wake Forest University School of Medicine, Section of Pulmonary, Critical Care, Allergy and Immunologic Diseases, Winston-Salem, NC 27157-1054, USA. johar@wfubmc.edu
authors.forename: Jill A
authors.initials: JA
authors.lastname: Ohar
authors.forename: Elizabeth J
authors.initials: EJ
authors.lastname: Ampleford
authors.forename: Suzanne E
authors.initials: SE
authors.lastname: Howard
authors.forename: David A
authors.initials: DA
authors.lastname: Sterling
mesh_terms: D000367:Age Factors; D000368:Aged; D001194:Asbestos / Q000009:adverse effects*; D004522:Educational Status; D005192:Family Health; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000401:mortality; D008297:Male; D008654:Mesothelioma / Q000235:genetics* / Q000401:mortality; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary; D009784:Occupational Diseases / Q000235:genetics* / Q000401:mortality; D016273:Occupational Exposure / Q000009:adverse effects; D010534:Peritoneal Neoplasms / Q000235:genetics / Q000401:mortality; D010641:Phenotype; D010997:Pleural Neoplasms / Q000235:genetics / Q000401:mortality; D012307:Risk Factors; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D001194:Asbestos